Martin Bionics Innovations, LLC
How we got $18.0M
Based on 41 employees reported for PPP in 2020, grown at the industry's Oklahoma rate since.
What we know
Signs of a sale Some signs of a sale
- In business 21 years (since 2005)
- Founder still runs it after 21 years
From public records and the company's website, not a statement that it's for sale.
What they do
Martin Bionics Innovations offers its Socket-less Socket™ prosthetic socket technology for amputees, delivered through its own clinics and a Clinical Network of trained practitioners.
From the company's website. Industry: Research and Development in Biotechnology (except Nanobiotechnology).
Customers & suppliers
Customers
- Department of Veterans Affairs · federal contracts $3.1M
Estimated value over time
▲ 16% since 2020Today's estimate scaled by the headcount reported each year and that year's prices. A trend, not a record of past sale values.
Employees over time
▲ 71% since 2020Show as table
| Year | Source | Employees | Est. revenue |
|---|---|---|---|
| 2020 | PPP loan | 41 | $15.5M |
| 2022 | Form 5500 | 56 | $21.1M |
| 2023 | Form 5500 | 55 | $20.8M |
| 2024 | Form 5500 | 61 | $23.0M |
| 2025 | Form 5500 | 70 | $26.4M |
Participants are employees in the company's retirement plan at year end, from its Form 5500 filing with the Department of Labor. They usually run a little under total headcount (part-timers and new hires may not be eligible). Revenue and EBITDA apply this industry's revenue per employee and margin to each year's count.
Compared with similar businesses nearby
| Business | Est. revenue | Distance |
|---|---|---|
| MARTIN BIONICS INNOVATIONS, LLC this business | $24.4M | — |
| COARE BIOTECHNOLOGY Oklahoma City · 3 employees | $1.8M | 0.5 mi |
| DRIK, LLC Oklahoma City · 2 employees | $1.1M | 0.5 mi |
| MEDCENTIVE, LLC Oklahoma City · 4 employees | $1.7M | 0.5 mi |
| MOLECULERA LABS, INC Oklahoma City · 14 employees | $5.8M | 0.5 mi |
| Oklahoma Center for the Advancement of Science and Technology (OCAST) Oklahoma City | $1.9M | 0.6 mi |
| CENTURY VENTURE PARTNERS LLC Oklahoma City · 1 employees | $437K | 0.6 mi |
The full calculation
| Employees reported to the SBA | 41 |
| Industry revenue per employee | $377K |
| Revenue = employees × revenue per employee | $24.4M |
| EBITDA margin (industry, adjusted for size) | 13% |
| EBITDA = revenue × margin | $3.3M |
| Cross-check: revenue implied by PPP payroll | $6.1M |
Figures are shown toward the upper part of their range rather than at its middle.
Brought up to date assuming revenue has grown 8% a year since 2020, when the PPP figures were reported; included above.
| Estimated value = EBITDA × typical sale multiple | $18.0M |
| Multiple for this size and industry | 5.5× |
| Value range | $8.5M – $25.5M |
| Revenue range | $14.4M – $28.8M |
| EBITDA range | $1.9M – $3.9M |
| Industry (NAICS) | Research and Development in Biotechnology (except Nanobiotechnology) (541714) |
Low confidence: the employee-based and payroll-based estimates differ by more than 2×.
EBITDA margin: from IRS tax returns of S corporations in this industry (2019–2022), adjusted for company size: smaller companies typically run higher margins. EBITDA here is after owners' salaries.
Benchmarks: US Economic Census 2022. PPP loans were sized on 2019–2020 payroll, so figures reflect that period. These are statistical estimates, not reported financials. Full methodology
People & advisors
Advisors
- BankingBancFirstPPP / SBA lender
From the company's own website and public filings (DOL Form 5500, IRS Form 990, SBA). Roles are as stated there and may be out of date.
Banking relationships
| BancFirst 7(a) 2020, PPP 2020 | All 7,048 borrowers → |
From PPP and SBA loan records, which name the bank but not the individual banker.
PPP loans
| Approved | Draw | Amount | Jobs |
|---|---|---|---|
| 4/15/2020 | first | $295K | 41 |
Public records
| Mar 2020 | 7(a) | $250K |
| Mar 2020 | 7(a) | $250K |
| Mar 2020 | 7(a) | $250K |
| Mar 2020 | 7(a) | $250K |
| Mar 2020 | 7(a) | $250K |
Matched to this business by name and address from public government data; a match can occasionally be wrong.
About Martin Bionics Innovations, LLC
Martin Bionics Innovations, LLC is a research and development in biotechnology (except nanobiotechnology) company in Oklahoma City, Oklahoma, in business since 2005. It is owned by Jay Martin (Founder). Its estimated annual revenue is about $24.4M, with roughly $3.3M of EBITDA. It has about 70 employees. Its estimated business value is $18.0M (likely range $8.5M–$25.5M).
Common questions
- Who owns Martin Bionics Innovations, LLC?
- Martin Bionics Innovations, LLC is owned by Jay Martin (Founder), according to public sources such as the company's website or filings.
- How much revenue does Martin Bionics Innovations, LLC make?
- SeeBITDA estimates Martin Bionics Innovations, LLC's annual revenue at about $24.4M (likely between $14.4M and $28.8M), based on public records such as its PPP loan and retirement-plan filings, brought up to 2026.
- What is Martin Bionics Innovations, LLC worth?
- About $18.0M, roughly 5.5× its estimated EBITDA of $3.3M, typical for a research and development in biotechnology (except nanobiotechnology) company its size. Likely range: $8.5M–$25.5M.
- How many employees does Martin Bionics Innovations, LLC have?
- About 70, from its 2025 retirement-plan filing.
- When was Martin Bionics Innovations, LLC founded?
- Martin Bionics Innovations, LLC has been in business since 2005.